| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 39,1 k € | -26.0% | 52,8 k € | +217.5% | 16,6 k € | -80.2% | 84,1 k € | +83.5% | 45,8 k € | -37.5% | 73,3 k € | +95.6% | 37,5 k € | -48.8% | 73,2 k € | +3.5% | 70,8 k € | -1.4% | 71,7 k € | -6.7% | 76,8 k € | +26.0% | 61,0 k € | +65.8% | 36,8 k € | +10.2% | 33,4 k € | +27.5% | 26,2 k € | +4.7% | 25,0 k € | -21.8% | 32,0 k € | +2.8% | 31,1 k € | +23.3% | 25,2 k € | |
| EBITDA | 35,1 k € | -31.0% | 50,9 k € | +235.7% | 15,2 k € | -81.6% | 82,4 k € | +86.8% | 44,1 k € | -36.8% | 69,8 k € | +109.5% | 33,3 k € | -52.4% | 70,1 k € | +4.2% | 67,3 k € | -1.1% | 68,0 k € | -6.2% | 72,5 k € | +25.1% | 58,0 k € | +69.1% | 34,3 k € | +66.8% | 20,6 k € | -13.8% | 23,9 k € | +8.4% | 22,0 k € | -24.5% | 29,2 k € | +1.1% | 28,9 k € | +25.1% | 23,1 k € | |
| Operating profit | 20,3 k € | -43.4% | 35,9 k € | +931266.5% | 3,9 € | -100.0% | 67,5 k € | +127.6% | 29,6 k € | -46.9% | 55,8 k € | +261.2% | 15,5 k € | -69.9% | 51,3 k € | +5.3% | 48,7 k € | -2.4% | 49,9 k € | -9.4% | 55,1 k € | +30.6% | 42,2 k € | +126.9% | 18,6 k € | +234.3% | 5,6 k € | +29.9% | 4,3 k € | +31.9% | 3,2 k € | -68.5% | 10,3 k € | -4.2% | 10,8 k € | +128.8% | 4,7 k € | |
| Profit/loss | 11,4 k € | -51.4% | 23,5 k € | +812.1% | -3,3 k € | -107.2% | 45,8 k € | +140.1% | 19,1 k € | -49.5% | 37,7 k € | +336.0% | 8,7 k € | -70.8% | 29,6 k € | +4.7% | 28,3 k € | -9.9% | 31,4 k € | -8.4% | 34,3 k € | +35.2% | 25,4 k € | +200.3% | 8,4 k € | +405.2% | -2,8 k € | -135.9% | -1,2 k € | -273.6% | 675,5 € | -88.2% | 5,7 k € | -6.6% | 6,1 k € | +206.1% | 2,0 k € | |
| Equity | 343,0 k € | +3.4% | 331,6 k € | +7.6% | 308,1 k € | -1.1% | 311,4 k € | +17.2% | 265,6 k € | +7.7% | 246,5 k € | +18.1% | 208,8 k € | +4.3% | 200,2 k € | +17.4% | 170,6 k € | +19.9% | 142,3 k € | +28.3% | 110,9 k € | +44.8% | 76,6 k € | +49.5% | 51,2 k € | +19.7% | 42,8 k € | -6.1% | 45,5 k € | -2.5% | 46,7 k € | +1.5% | 46,0 k € | +14.2% | 40,3 k € | +18.0% | 34,1 k € | |
| Total assets | 418,6 k € | -2.0% | 427,1 k € | +14.1% | 374,2 k € | -3.2% | 386,4 k € | +12.7% | 342,9 k € | +0.3% | 341,8 k € | +8.3% | 315,8 k € | +1.6% | 310,9 k € | +5.0% | 296,2 k € | +6.4% | 278,3 k € | -0.6% | 280,1 k € | +6.6% | 262,8 k € | +6.7% | 246,2 k € | -4.3% | 257,2 k € | +33.3% | 193,0 k € | +150.9% | 76,9 k € | -14.5% | 90,0 k € | +9.5% | 82,2 k € | -13.7% | 95,3 k € | |
| Cash | 153,7 k € | -0.8% | 155,0 k € | +61.7% | 95,9 k € | -16.8% | 115,2 k € | +57.2% | 73,3 k € | +8.5% | 67,6 k € | +117.8% | 31,0 k € | -31.2% | 45,1 k € | +138.0% | 18,9 k € | -5.4% | 20,0 k € | -70.9% | 68,8 k € | +48.0% | 46,5 k € | +162.5% | 17,7 k € | -16.7% | 21,2 k € | +25.6% | 16,9 k € | +43.7% | 11,8 k € | -26.2% | 15,9 k € | +22.4% | 13,0 k € | +54.8% | 8,4 k € | |
| Debts | 75,6 k € | -20.9% | 95,5 k € | +44.4% | 66,1 k € | -11.9% | 75,0 k € | -2.9% | 77,3 k € | -18.9% | 95,3 k € | -10.9% | 107,0 k € | -3.4% | 110,7 k € | -11.9% | 125,6 k € | -7.6% | 136,0 k € | -19.6% | 169,3 k € | -9.1% | 186,2 k € | -4.5% | 195,0 k € | -9.1% | 214,4 k € | +45.5% | 147,4 k € | +388.0% | 30,2 k € | -31.3% | 44,0 k € | +5.0% | 41,9 k € | -31.5% | 61,1 k € | |
Private company with limited liability · Bertrix · incorporated on 28/08/1998
Private company with limited liability profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
GENEX - MED is a Private company with limited liability incorporated in 1998. Its main activity is: General medical practice activities. Its registered office is in Bertrix.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette